|
Phase II study investigating the efficacy and safety of glesatinib (MGCD265) in patients with advanced NSCLC containing MET activating alterations |
|
|
|
Titel: |
Phase II study investigating the efficacy and safety of glesatinib (MGCD265) in patients with advanced NSCLC containing MET activating alterations |
Auteur: |
Hong, David S. Cappuzzo, Federico Chul Cho, Byoung Dowlati, Afshin Hussein, Maen Kim, Dong-Wan Percent, Ivor Christensen, James G. Morin, Josée Potvin, Diane Faltaos, Demiana Tassell, Vanessa Der-Torossian, Hirak Chao, Richard |
Verschenen in: |
Lung cancer |
Paginering: |
Jaargang 190 () nr. C pagina's p. |
Jaar: |
2024 |
Inhoud: |
|
Uitgever: |
Published by Elsevier B.V. |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|